Riskpilot← Back to searchSign inGet full accessGC Danmark ApS
APSActiveCVR 42224391Buen 11, 6.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20212 employees
Revenue 2025
DKK 1,9M
+7% vs 2024
EBITDA margin
8.6%
-5% vs 2024
Equity ratio
57.2%
Financial strength
Net profit 2025
DKK 103K
-20% vs 2024
| Revenue | DKK 1,9M | +7% |
| EBITDA | DKK 163K | -5% |
| Net profit | DKK 103K | -20% |
| Total assets | DKK 596K | -7% |
| Equity | DKK 341K | +13% |
| Employees | 2 | — |
Legal name
GC Danmark ApS
CVR number
42224391
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. marts 2021
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med salg og markedsføring af dentalprodukter, tandplejetilbehør og tandlæge produkter samt dermed beslægtet virksomhed.
Address
Buen 11, 6.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 2.453 | 1.676 | 1.774 | 1.904 |
| Staff expenses | -2.222 | -1.498 | -1.602 | -1.741 |
| EBITDA | 230 | 178 | 172 | 163 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | 230 | 178 | 172 | 163 |
| Net financials | -35 | -23 | -15 | -5 |
| Profit before tax | 195 | 155 | 157 | 158 |
| Tax | 49 | 38 | 29 | 56 |
| Net profit | 146 | 117 | 128 | 103 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 799 | 504 | 642 | 596 |
| Equity | 186 | 229 | 302 | 341 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 612 | 275 | 340 | 255 |
| Total debt | 612 | 275 | 340 | 255 |
EBITDA margin
8.6%
This company
15.8%
Market median
-46% vs market
20222025
Equity ratio
57.2%
This company
38.2%
Market median
+50% vs market
20222025
Return on equity
30.1%
This company
18.4%
Market median
+64% vs market
20222025
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
20222025
Asset turnover
3.20×
This company
1.12×
Market median
+186% vs market
20222025
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20222025
- Annual report 2025Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-03-10 – 2022-03-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JO Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GC Danmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jyrki Olavi Kurokallio | Management | 0 companies |
| Frank Michael Rosenbaum | Board of Directors | 0 companies |
| Katrin Langer | Board of Directors | 0 companies |
| Josef Richter | Board of Directors | 0 companies |
| Dries Julia W. Baets | Board of Directors | 0 companies |